Estimator data drawn from NEJM-published Phase 3 trials (SURMOUNT-1 Jastreboff 2022, STEP-1 Wilding 2021, SCALE Pi-Sunyer 2015) and Phase 2 retatrutide data (NEJM Jastreboff/Kaplan 2023)
According to research published in JAMA, those who discontinue may gain more weight during pregnancy than those never on treatment
That oh my god, what what did I just do right
Citicoline significantly restored the phosphatidylcholine, sphingomyelin, and cardiolipin levels but did not affect phosphatidylinositol and phosphatidylserine at 1 day
In the phase 3b OASIS 4 trial, once-daily oral semaglutide 25 mg demonstrated a mean weight loss of 16.6% among adults with obesity or overweight and at least one weight-related comorbidity when treatment was adhered to, based on the trial product estimand
Kubota S, Liu Y, Iizuka K, Kuwata H, Seino Y, Yabe D